What is AdMed?
For over 28 years, AdMed, Inc. has solidified its reputation as a leader in providing comprehensive medical education and training solutions tailored for the pharmaceutical and biotechnology industries. The company excels in developing innovative, web-based interactive educational programs across a broad spectrum of therapeutic categories. AdMed's expertise extends to creating engaging and scientifically rigorous content through diverse media, including web, video, animation, and print, ensuring complex medical information is both accessible and educational. Their commitment to excellence is reflected in their experienced-based salaries and robust benefits package, including medical, dental, and vision coverage, a profit-sharing program, and other employee-centric perks, positioning them as a desirable employer in the medical information and education space.
How much funding has AdMed raised?
AdMed has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for AdMed?
The substantial capital infusion, indicated by the $350K in total funding and the recent $350K strategic investment, signals AdMed's readiness for accelerated expansion and innovation. As a company deeply entrenched in late-stage development within the medical education technology sector, this financing is likely to fuel advancements in their multimedia content creation capabilities, enhance their interactive sales training solutions, and potentially broaden their market reach. AdMed is poised to leverage this financial momentum to further solidify its leadership in delivering cutting-edge educational and training resources to the pharmaceutical and biotechnology markets, reinforcing its commitment to scientific accuracy and engaging content delivery.
See full AdMed company page
